EMS SA - Strategic SWOT Analysis Review

November 2021 | 31 pages | ID: E047C886277EN
GlobalData

Abstracts

EMS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

EMS SA (EMS), a subsidiary of Grupo NC, is a pharmaceutical company that focuses on the development of products for the improvement of health and well-being of the population. It operates in the segments of medical prescription, generics, branded pharmaceuticals, manufacturing products, OTC and hospitals. The company’s major product portfolio includes drugs in the therapeutic areas of anti-inflammatories, analgesics, antihypertensives, anthelmintics, antidiabetics, antibiotics, anti-ulcers, topical corticosteroids, and anti-flu. EMS has production units in Sao Bernardo do Campo, Jaguariuna and Hortolandia in Sao Paulo; Novamed, Manaus in Amazonas; and Brasilia in Federal District. The company is certified by European Medicines Agency. EMS is headquartered in Hortolandia, Brazil.

EMS SA Key Recent Developments

Mar 01,2021: EMS invests r$ 2 million in an integrated digital commercial management system
Feb 01,2021: EMS donates R$ 2 million in medicines and hospital equipment to fight the pandemic in Manaus
Sep 28,2020: EMS wins Epoca Negocios 360? Award for most innovative company in Brazil
Apr 24,2020: Anvisa approves third EMS clinical study to evaluate drug efficacy in combating the new coronavirus
Mar 27,2020: Anvisa approves the start of clinical studies supported by EMS for the use of hydroxychloroquine in patients with coronavirus

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

EMS SA - Key Facts
EMS SA - Key Employees
EMS SA - Key Operational Employees
EMS SA - Major Products and Services
EMS SA - History
EMS SA - Company Statement
EMS SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
EMS SA - Business Description
EMS SA - Corporate Strategy
EMS SA - SWOT Analysis
SWOT Analysis - Overview
EMS SA - Strengths
EMS SA - Weaknesses
EMS SA - Opportunities
EMS SA - Threats
EMS SA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

EMS SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
EMS SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
EMS SA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Mar 01, 2021: EMS invests r$ 2 million in an integrated digital commercial management system
Feb 01, 2021: EMS donates R$ 2 million in medicines and hospital equipment to fight the pandemic in Manaus
Sep 28, 2020: EMS wins Epoca Negocios 360? Award for most innovative company in Brazil
Apr 24, 2020: Anvisa approves third EMS clinical study to evaluate drug efficacy in combating the new coronavirus
Mar 27, 2020: Anvisa approves the start of clinical studies supported by EMS for the use of hydroxychloroquine in patients with coronavirus

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

EMS SA, Key Facts
EMS SA, Key Employees
EMS SA, Key Operational Employees
EMS SA, Major Products and Services
EMS SA, History
EMS SA, Other Locations
EMS SA, Subsidiaries
EMS SA, Joint Venture
EMS SA, Key Competitors
EMS SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
EMS SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
EMS SA, Recent Deals Summary

List Of Figures

LIST OF FIGURES

EMS SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
EMS SA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021